kolaviron has been researched along with aflatoxin b1 in 2 studies
| Studies (kolaviron) | Trials (kolaviron) | Recent Studies (post-2010) (kolaviron) | Studies (aflatoxin b1) | Trials (aflatoxin b1) | Recent Studies (post-2010) (aflatoxin b1) |
|---|---|---|---|---|---|
| 103 | 0 | 73 | 4,532 | 49 | 1,715 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Emerole, GO; Nwankwo, JO; Tahnteng, JG | 1 |
| Adepoju, BF; Emerole, GO; Farombi, EO; Ola-Davies, OE | 1 |
2 other study(ies) available for kolaviron and aflatoxin b1
| Article | Year |
|---|---|
Inhibition of aflatoxin B1 genotoxicity in human liver-derived HepG2 cells by kolaviron biflavonoids and molecular mechanisms of action.
Topics: Aflatoxin B1; Blotting, Northern; Blotting, Western; Butylated Hydroxyanisole; Cells, Cultured; Cytochrome P-450 Enzyme System; Flavonoids; Glutathione Transferase; Humans; Liver; Mutagens; Plant Extracts; Plants, Medicinal; Polymerase Chain Reaction; Thymidine | 2000 |
Chemoprevention of aflatoxin B1-induced genotoxicity and hepatic oxidative damage in rats by kolaviron, a natural bioflavonoid of Garcinia kola seeds.
Topics: Administration, Oral; Aflatoxin B1; Animals; Chemoprevention; Dose-Response Relationship, Drug; Flavonoids; Food Contamination; Infusions, Parenteral; Liver; Male; Oxidative Stress; Rats; Rats, Wistar | 2005 |